Literature DB >> 10573077

Transplantation of allogeneic or xenogeneic bone marrow within the donor stromal microenvironment.

O Gurevitch1, T B Prigozhina, T Pugatsch, S Slavin.   

Abstract

Successful engraftment of hematopoietic stem cells requires a supportive hematopoietic stromal microenvironment (HSM). Defects in the HSM associated with aplastic anemia, myelofibrosis, or caused by intensive ionizing radiation and chemotherapy generally result in failure of bone marrow (BM) engraftment. Transplantation of donor BM within donor HSM may therefore provide optimal conditions for allogeneic BM transplantation. We have transplanted donor hematopoietic cells together with their own HSM to improve acceptance of allogeneic or xenogeneic BM. The non-myeloablative treatment used induced tolerance to murine allografts and provided conditions for the life-long acceptance of allogeneic HSM. Allogeneic BM transplanted within it's own HSM under the kidney capsule caused less graft-versus-host disease than BM transplanted i.v. Tolerance in mice to xenogeneic (rat) HSM was less complete. Ectopic ossicles were small and contained fewer hematopoietic cells. However, simultaneous transplantation of rat BM and HSM to preconditioned mice improved engraftment of rat BM compared with transplantation of BM alone. Donor hematopoietic cells survived longer on their own HSM than on HSM of recipients.

Entities:  

Mesh:

Year:  1999        PMID: 10573077     DOI: 10.1097/00007890-199911150-00024

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  11 in total

1.  An in vivo model to study and manipulate the hematopoietic stem cell niche.

Authors:  Junhui Song; Mark J Kiel; Zhou Wang; Jingcheng Wang; Russell S Taichman; Sean J Morrison; Paul H Krebsbach
Journal:  Blood       Date:  2010-01-28       Impact factor: 22.113

2.  Cotransplantation of marrow stromal cells may prevent lethal graft-versus-host disease in major histocompatibility complex mismatched murine hematopoietic stem cell transplantation.

Authors:  Nak Gyun Chung; Dae Chul Jeong; Soo Jeong Park; Byung Ock Choi; Bin Cho; Hack Ki Kim; Chung Sik Chun; Jong Ho Won; Chi Wha Han
Journal:  Int J Hematol       Date:  2004-11       Impact factor: 2.490

Review 3.  Composite tissue transplantation: a rapidly advancing field.

Authors:  K V Ravindra; S Wu; L Bozulic; H Xu; W C Breidenbach; S T Ildstad
Journal:  Transplant Proc       Date:  2008-06       Impact factor: 1.066

Review 4.  Effects of erythropoietin on the bone microenvironment.

Authors:  S J McGee; A M Havens; Y Shiozawa; Y Jung; R S Taichman
Journal:  Growth Factors       Date:  2011-11-28       Impact factor: 2.511

5.  Immune Modulation by Mesenchymal Stem Cells.

Authors:  Francesco Bifari; Veronica Lisi; Elda Mimiola; Annalisa Pasini; Mauro Krampera
Journal:  Transfus Med Hemother       Date:  2008-05-16       Impact factor: 3.747

6.  Erythropoietin couples hematopoiesis with bone formation.

Authors:  Yusuke Shiozawa; Younghun Jung; Anne M Ziegler; Elisabeth A Pedersen; Jianhua Wang; Zhuo Wang; Junhui Song; Jingcheng Wang; Clara H Lee; Sudha Sud; Kenneth J Pienta; Paul H Krebsbach; Russell S Taichman
Journal:  PLoS One       Date:  2010-05-27       Impact factor: 3.240

Review 7.  Transplantation of hematopoietic stem cells for induction of unresponsiveness to organ allografts.

Authors:  Tatyana Prigozhina; Shimon Slavin
Journal:  Springer Semin Immunopathol       Date:  2004-09-11

8.  Paracrine molecules of mesenchymal stem cells for hematopoietic stem cell niche.

Authors:  Tian Li; Yaojiong Wu
Journal:  Bone Marrow Res       Date:  2011-09-22

Review 9.  The need for inducing tolerance in vascularized composite allotransplantation.

Authors:  Kadiyala V Ravindra; Hong Xu; Larry D Bozulic; David D Song; Suzanne T Ildstad
Journal:  Clin Dev Immunol       Date:  2012-10-31

Review 10.  Effects of Mesenchymal Stem Cell Derivatives on Hematopoiesis and Hematopoietic Stem Cells.

Authors:  Sara Aqmasheh; Karim Shamsasanjan; Parvin Akbarzadehlaleh; Davod Pashoutan Sarvar; Hamze Timari
Journal:  Adv Pharm Bull       Date:  2017-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.